DBD
DBD
NYSE · Technology

Diebold Nixdorf Inc

$57.59
-0.39 (-0.67%)
As of Nov 5, 8:46 PM ET ·
Financial Highlights (FY 2026)
Revenue
3.26B
Net Income
80.97M
Gross Margin
26.4%
Profit Margin
2.5%
Rev Growth
+3.2%
D/E Ratio
0.86
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 26.4% 26.4% 62.0% 62.0%
Operating Margin 6.4% 5.7% 23.8% 24.5%
Profit Margin 2.5% 2.4% 21.9% 24.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 3.26B 3.16B 350.37M 397.27M
Gross Profit 858.95M 832.16M 217.38M 246.48M
Operating Income 207.16M 180.63M 83.22M 97.46M
Net Income 80.97M 70.60M 76.72M 98.58M
Gross Margin 26.4% 26.4% 62.0% 62.0%
Operating Margin 6.4% 5.7% 23.8% 24.5%
Profit Margin 2.5% 2.4% 21.9% 24.8%
Rev Growth +3.2% +3.2% +6.5% +14.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 427.12M 427.12M 538.36M 459.72M
Total Equity 497.34M 497.34M 1.05B 1.01B
D/E Ratio 0.86 0.86 0.51 0.46
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 316.26M 291.07M 102.75M 125.92M
Free Cash Flow — — 87.64M 93.06M